FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4392111000001105: Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1736241000001117 Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1736251000001119 Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Is a Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has active ingredient Imipenem false Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has active ingredient Cilastatin false Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has active ingredient Cilastatin sodium false Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has active ingredient Imipenem monohydrate false Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has manufactured dose form Powder for conventional release suspension for injection false Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Is a Primaxin IM true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has specific active ingredient Imipenem monohydrate false Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has specific active ingredient Cilastatin sodium false Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has dispensed dose form Powder for conventional release suspension for injection true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has specific active ingredient Imipenem monohydrate true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has specific active ingredient Cilastatin sodium true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) 1 vial Is pack of False Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) 1 vial Has AMP True Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start